A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases

NCT07357220 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer With Hepatic Metastases

Interventions

BIOLOGICAL: VG2025
DRUG: AK112

Sponsor

Akeso

Collaborators

[object Object]